Advanced search
Publication Cover
Expert Review of Respiratory Medicine Volume 12, 2018 - Issue 4
Submit an article Journal homepage
3,810
Views
5
CrossRef citations to date
0
Altmetric
Editorial

Dual LABA/LAMA bronchodilators in chronic obstructive pulmonary disease: why, when, and how

Luigino CalzettaDepartment of Experimental Medicine and Surgery, University of Rome “Tor Vergata”, Rome, ItalyCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-0456-069X
ORCID Icon,
Maria Gabriella MateraDepartment of Experimental Medicine, Unit of Pharmacology, University of Campania “Luigi Vanvitelli”, Naples, Italy
,
Paola RoglianiDepartment of Experimental Medicine and Surgery, University of Rome “Tor Vergata”, Rome, ItalyORCID Iconhttp://orcid.org/0000-0001-7801-5040
ORCID Icon &
Mario CazzolaDepartment of Experimental Medicine and Surgery, University of Rome “Tor Vergata”, Rome, ItalyORCID Iconhttp://orcid.org/0000-0003-4895-9707
ORCID Icon
Pages 261-264 | Received 06 Dec 2017, Accepted 14 Feb 2018, Published online: 19 Feb 2018

References

  • Calzetta L, Rogliani P, Facciolo F, et al. Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchi. Eur J Pharmacol. 2017;812:147–154.
  • Calzetta L, Ora J, Cavalli F, et al. Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: a pair-wise and network meta-analysis. Respir Med. 2017;129:189–198.
  • Calzetta L, Rogliani P, Ora J, et al. LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment. Eur Respir Rev. 2017;26:1–11.
  • Calzetta L, Rogliani P, Matera MG, et al. A systematic review with meta-analysis of dual bronchodilation with LAMA/LABA for the treatment of stable COPD. Chest. 2016;149:1181–1196.
  • Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev. 2006;58:621–681.
  • Calzetta L, Matera MG, Cazzola M. Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy. Eur J Pharmacol. 2015;761:168–173.
  • Cazzola M, Calzetta L, Page CP, et al. Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi. Eur J Pharmacol. 2014;745:135–143.
  • Cazzola M, Calzetta L, Puxeddu E, et al. Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells. Respir Res. 2016;17:70.
  • Cazzola M, Calzetta L, Ora J, et al. Searching for the synergistic effect between aclidinium and formoterol: from bench to bedside. Respir Med. 2015;109:1305–1311.
  • Cazzola M, Calzetta L, Segreti A, et al. Translational study searching for synergy between glycopyrronium and indacaterol. COPD. 2015;12:175–181.
  • Rogliani P, Calzetta L, Ora J, et al. Clinical synergism of LABA/LAMA combinations in COPD patients. 1814. ERS Congress; 2017 Sep; Milan, Italy. Available from: http://www.ers-education.org/home/browse-all-content.aspx?idParent=184261.
  • Donohue JF, Singh D, Munzu C, et al. Magnitude of umeclidinium/vilanterol lung function effect depends on monotherapy responses: results from two randomised controlled trials. Respir Med. 2016;112:65–74.
  • Calzetta L, Rogliani P, Cavalli F, et al. Protein tyrosin kinase and KCa++ cannel: two faces of the same coin in LABA/LAMA synergy. 4407. ERS Congress; 2017 Sep; Milan, Italy. Available from: http://www.ers-education.org/home/browse-all-content.aspx?idParent=186759
  • Cohen JS, Miles MC, Donohue JF, et al. Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA. Int J Chron Obstruct Pulmon Dis. 2016;11:785–797.
  • Wedzicha JA, Zhong N, Ichinose M, et al. Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study. Int J Chron Obstruct Pulmon Dis. 2017;12:339–349.
  • Cazzola M, Beeh KM, Price D, et al. Assessing the clinical value of fast onset and sustained duration of action of long-acting bronchodilators for COPD. Pulm Pharmacol Ther. 2015;31:68–78.
  • Cazzola M, Page CP, Rogliani P, et al. beta2-agonist therapy in lung disease. Am J Respir Crit Care Med. 2013;187:690–696.
  • Beeh KM, Beier J. The short, the long and the “ultra-long”: why duration of bronchodilator action matters in chronic obstructive pulmonary disease. Adv Ther. 2010;27:150–159.
  • GOLD. Global initiative for chronic obstructive lung disease. Global strategy for diagnosis, management, and prevention of COPD – 2017 Report. 2017. [cited 2018 Jan 13]. Available from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/
  • Calzetta M, Rogliani P, Facciolo F, et al. Interaction between tiotropium bromide and olodaterol in human bronchial smooth muscle. C73 new mechanisms and therapies in copd: Am Thoracic Soc; 2017. p. A6274–A. DOI:10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A6274.
  • Tashkin DP. The safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease. Expert Opin Drug Saf. 2015;14:1759–1772.
  • Rogliani P, Calzetta L, Coppola A, et al. Optimizing drug delivery in COPD: the role of inhaler devices. Respir Med. 2017;124:6–14.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.